National Cancer Institute shared a post on LinkedIn:
“Rare cancers affect fewer than 40,000 people each year, but together they account for more than a quarter of all cancer diagnoses and deaths in the United States.
Through the MyPART Network, NCI is helping connect patients, families, clinicians, and researchers to advance research, expand collaboration, and accelerate progress against these often-overlooked diseases. By fostering collaboration, expanding research opportunities, and improving access to expertise, we can help ensure that people affected by rare cancers benefit from the same scientific advances transforming cancer care more broadly.”
Other articles about NCI on OncoDaily.